Standard BioTools Inc. logo LAB - Standard BioTools Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 6
HOLD 4
SELL 0
STRONG
SELL
0
| PRICE TARGET: $3.25 DETAILS
HIGH: $3.25
LOW: $3.25
MEDIAN: $3.25
CONSENSUS: $3.25
UPSIDE: 215.53%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Revenue
Revenue 85.3 174.4 106.3 97.9 130.6 138.1 117.2 113.0 101.9 104.4 114.7 116.5 71.2 52.3 42.9 33.6 25.4 15.3 7.3 6.4
Cost of Revenue 42.8 90.2 55.9 60.9 61.2 54.8 53.0 51.3 50.0 46.0 46.6 42.8 20.1 15.3 13.2 11.6 11.5 8.4 3.5 2.8
Gross Profit 42.5 84.3 50.5 37.1 69.4 83.3 64.3 61.6 52.0 58.4 68.1 73.6 51.1 37.0 29.7 22.0 13.9 7.0 3.8 3.6
Operating Expenses
R&D Expenses 26.0 62.4 25.9 37.4 37.9 36.5 31.6 30.0 30.8 38.4 39.3 43.4 19.7 16.6 13.9 13.0 12.3 14.0 14.4 15.6
SG&A Expenses 109.9 156.6 87.5 102.3 98.9 97.9 84.5 79.8 79.5 93.2 83.0 71.3 48.1 38.5 31.3 23.5 19.6 22.5 12.9 9.7
Other Expenses 0 40.5 13.6 13.6 0 0 0 0.6 0.4 (1.2) (1.2) (0.9) 0.5 (0.2) 0 0 0 0 0 0
Operating Expenses 135.8 259.5 127.0 153.3 136.8 134.4 116.1 109.8 110.3 131.6 122.2 114.7 67.8 55.1 45.2 36.6 32.0 36.5 27.3 25.3
Operating Income
Operating Income (93.3) (175.2) (76.6) (116.2) (67.5) (51.0) (51.8) (48.2) (58.4) (73.2) (50.2) (51.8) (17.9) (18.1) (18.6) (14.6) (18.0) (29.5) (23.5) (21.7)
Interest Expense 0.0 3.3 4.6 4.3 3.8 3.6 4.3 13.9 5.8 5.8 5.8 5.3 0.0 0.6 3.1 2.2 2.9 2.0 2.8 2.3
Interest Income 9.2 20.2 5.6 2.2 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0.8 1.1 0.6
Profitability
EBITDA (86.3) (118.1) (54.5) (173.6) (44.3) (34.6) (46.6) (31.0) (39.7) (56.4) (32.9) (38.5) (13.8) (16.8) (18.1) (13.5) (14.7) (26.1) (20.9) (19.8)
EBIT (93.3) (135.0) (69.6) (188.6) (59.8) (50.5) (62.4) (47.5) (58.0) (74.4) (49.0) (52.4) (16.4) (18.3) (19.2) (14.7) (16.3) (27.6) (22.6) (21.3)
Income Before Tax (96.7) (138.3) (74.2) (192.9) (63.7) (54.1) (66.7) (61.4) (63.8) (80.2) (54.8) (57.7) (15.7) (18.9) (22.3) (16.8) (19.2) (29.6) (25.3) (23.6)
Income Tax Expense (37.9) 0.6 0.5 (2.8) (4.4) (1.1) (1.9) (2.4) (3.3) (4.2) (1.5) (4.9) 0.1 0.1 0.2 0.1 (0.1) (0.1) 0.1 0.2
Net Income (74.9) (138.9) (74.7) (190.1) (59.2) (53.0) (64.8) (59.0) (60.5) (76.0) (53.3) (52.8) (15.8) (19.0) (22.5) (16.9) (19.1) (29.5) (25.5) (23.6)
Per Share Data
EPS (Basic) -0.20 -0.52 -0.94 -2.43 -0.78 -0.74 -0.97 -1.49 -1.84 -2.62 -1.86 -1.90 -0.62 -0.86 -1.26 -0.89 -11.02 -17.85 -13.47 -12.46
EPS (Diluted) -0.20 -0.52 -0.94 -2.43 -0.78 -0.74 -0.97 -1.49 -1.84 -2.62 -1.86 -1.90 -0.62 -0.86 -1.26 -0.89 -11.02 -17.85 -13.47 -12.46
Shares Outstanding 381.6 352.7 79.2 78.3 75.8 72.0 66.8 39.7 33.0 29.0 28.7 27.8 25.5 22.1 17.8 19.0 1.7 1.7 1.9 1.9
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008
Current Assets
Cash & Cash Equivalents 118.2 166.7 51.7 81.3 28.5 68.5 21.7 95.4 58.1 35.0 14.6 17.8
Short-Term Investments 69.4 126.1 63.2 84.5 0 0 37.0 0 5.1 24.4 0 0
Net Receivables 13.4 33.6 19.7 17.3 18.3 25.4 19.0 16.7 15.0 14.6 8.7 4.7
Inventory 20.0 40.7 20.5 21.5 20.8 19.7 13.9 13.0 15.1 20.1 3.9 5.5
Other Current Assets 233.3 8.7 3.1 4.3 0.0 0 0 2.1 1.5 2.5 0 0
Total Current Assets 454.3 375.9 158.2 208.8 72.1 117.7 96.1 127.1 94.8 96.7 28.5 29.2
Non-Current Assets
Property, Plant & Equipment 46.0 71.4 54.9 59.5 65.2 55.6 12.9 8.8 12.3 16.5 1.9 2.8
Goodwill 0 111.3 106.3 106.3 106.4 106.6 104.1 104.1 104.1 104.1 0 0
Intangible Assets 0 29.0 1.4 12.6 27.9 42.2 49.1 57.4 68.6 79.8 0 0
Long-Term Investments 25.7 0 0 0 1 0 0 0 0 0 0 0
Other Non-Current Assets 3.2 24.8 2.3 3.1 3.7 2.7 2.6 6.2 7.5 9.3 1.7 0.4
Total Non-Current Assets 113.5 236.5 164.9 181.5 203.1 207.1 168.7 176.5 192.6 209.7 3.7 3.1
Total Assets 567.8 612.3 323.1 390.3 275.2 324.8 264.8 303.6 287.4 306.4 32.2 32.4
Current Liabilities
Account Payables 5.4 12.3 9.2 7.9 10.6 9.2 5.2 4.0 4.2 4.0 2.2 2.9
Short-Term Debt 5.5 0 59.5 2.1 6.8 0 0 0 0 0 0 1.0
Deferred Revenue 38.9 18.6 16.7 14.4 15.5 16.4 11.8 11.5 10.2 9.2 0.8 1.4
Other Current Liabilities 58.5 14.7 12.1 4.0 8.7 11.2 3.8 7.6 10.5 12.4 0.6 0.1
Total Current Liabilities 108.3 65.9 109.3 43.4 49.6 54.2 32.8 37.6 33.5 29.5 7.1 8.5
Non-Current Liabilities
Long-Term Debt 0.3 0.3 4.0 62.8 64.2 54.2 53.8 172.1 195.2 195.0 14.5 14.2
Deferred Tax Liabilities 0.8 1.1 0.8 1.1 4.3 8.7 11.5 13.7 16.9 21.1 183.8 167.5
Other Non-Current Liabilities 1.2 7.0 312.3 312.2 0.9 1.3 0.6 1.9 5.8 3.3 0.1 0.1
Total Non-Current Liabilities 35.2 74.7 361.8 428.3 131.1 131.5 78.4 193.9 222.9 223.7 198.6 182.2
Total Liabilities 143.5 140.6 471.1 471.8 180.6 185.7 111.2 231.5 256.4 253.2 205.8 190.7
Stockholders' Equity
Common Stock 0.4 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0
Retained Earnings (1,260.5) (1,185.7) (1,000.8) (926.1) (736.0) (676.8) (623.6) (558.9) (500.2) (439.5) (182.4) (163.3)
Accumulated Other Comprehensive Income (1.5) 1.2 (2.2) (1.9) (0.9) 0.1 (0.6) (0.7) (0.6) (0.8) (0.5) (0.6)
Total Stockholders' Equity 424.3 471.7 (148.1) (81.5) 94.6 139.1 153.6 72.1 30.9 53.2 (173.6) (158.3)
Total Liabilities & Equity 567.8 612.3 323.1 390.3 275.2 324.8 264.8 303.6 287.4 306.4 32.2 32.4
Debt Metrics
Total Debt 30.8 33.0 98.2 102.7 111.6 95.4 60.0 172.1 195.2 195.0 14.5 15.2
Net Debt (87.4) (133.7) 46.5 21.3 83.2 26.9 38.3 76.7 137.2 159.9 (0.1) (2.6)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (74.9) (138.9) (74.7) (190.1) (59.2) (53.0) (64.8) (59.0) (60.5) (76.0)
Depreciation & Amortization 1.7 16.9 15.2 15.0 16.2 15.9 17.7 16.6 18.6 17.9
Stock-Based Compensation 29.6 31.7 13.1 14.9 16.1 14.5 11.4 11.0 9.1 13.9
Change in Working Capital (45.0) (12.1) 1.8 (12.4) (18.0) 2.4 (16.5) (2.5) 9.2 4.8
Other Non-Cash Items 14.2 (41.1) 1.3 83.2 0.9 4.6 17.0 8.6 (0.5) 0.3
Operating Cash Flow (74.3) (143.5) (43.3) (89.4) (44.1) (15.4) (35.2) (25.2) (24.1) (39.1)
Investing Activities
Capital Expenditure (8.3) (8.4) (2.8) (3.8) (13.3) (12.7) (2.5) (0.4) (1.6) (5.1)
Acquisitions 0 278.6 0 0 0 (5.2) 0 0 0.1 2.3
Purchases of Investments (140.9) 0 (94.9) 0 0 0 0 (1.4) (6.3) (38.6)
Sales/Maturities of Investments 179 0 118.0 0 0 36.8 0 6.5 25.6 86.4
Other Investing Activities (5) 92.9 0 (84.3) 1.3 21.0 (36.8) 5.1 (0.1) 50.2
Investing Cash Flow 24.8 363.2 20.2 (88.1) (11.9) 40.0 (39.3) 4.7 17.7 45.1
Financing Activities
Net Debt Issuance 0 (63.2) (2.1) 18.2 9.5 0 3.2 0 0 0
Stock Repurchased 0 (40.9) (5.4) (0.8) (1.8) 0 (0.6) 0 0 (0.1)
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (0.5) 1.5 0.8 213.4 8.3 0.6 0.2 (1.8) 0.2 0.2
Financing Cash Flow 0.6 (102.6) (6.8) 230.8 16.0 20.9 2.8 57.7 29.0 0.1
Cash Position
Net Change in Cash (48.2) 116.3 (29.8) 52.9 (40.1) 45.8 (71.7) 37.3 23.0 5.9
Cash at Beginning 168.8 52.5 82.3 29.5 69.5 23.7 95.4 58.1 35.0 29.1
Cash at End 120.6 168.8 52.5 82.3 29.5 69.5 23.7 95.4 58.1 35.0
Free Cash Flow (82.7) (151.8) (46.1) (93.2) (57.3) (28.1) (37.7) (25.6) (25.7) (44.2)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Income Statement
Revenue 85.3 174.4 106.3 97.9 130.6 138.1 117.2 113.0 101.9 104.4 114.7 116.5 71.2 52.3 42.9 33.6 25.4 15.3 7.3 6.4
Gross Profit 42.5 84.3 50.5 37.1 69.4 83.3 64.3 61.6 52.0 58.4 68.1 73.6 51.1 37.0 29.7 22.0 13.9 7.0 3.8 3.6
Operating Income (93.3) (175.2) (76.6) (116.2) (67.5) (51.0) (51.8) (48.2) (58.4) (73.2) (50.2) (51.8) (17.9) (18.1) (18.6) (14.6) (18.0) (29.5) (23.5) (21.7)
Net Income (74.9) (138.9) (74.7) (190.1) (59.2) (53.0) (64.8) (59.0) (60.5) (76.0) (53.3) (52.8) (15.8) (19.0) (22.5) (16.9) (19.1) (29.5) (25.5) (23.6)
EPS (Diluted) -0.20 -0.52 -0.94 -2.43 -0.78 -0.74 -0.97 -1.49 -1.84 -2.62 -1.86 -1.90 -0.62 -0.86 -1.26 -0.89 -11.02 -17.85 -13.47 -12.46
Balance Sheet
Cash & Equivalents 118.2 166.7 51.7 81.3 28.5 68.5 21.7 95.4 58.1 35.0 14.6 17.8
Total Assets 567.8 612.3 323.1 390.3 275.2 324.8 264.8 303.6 287.4 306.4 32.2 32.4
Total Debt 30.8 33.0 98.2 102.7 111.6 95.4 60.0 172.1 195.2 195.0 14.5 15.2
Stockholders' Equity 424.3 471.7 (148.1) (81.5) 94.6 139.1 153.6 72.1 30.9 53.2 (173.6) (158.3)
Cash Flow
Operating Cash Flow (74.3) (143.5) (43.3) (89.4) (44.1) (15.4) (35.2) (25.2) (24.1) (39.1)
Capital Expenditure (8.3) (8.4) (2.8) (3.8) (13.3) (12.7) (2.5) (0.4) (1.6) (5.1)
Free Cash Flow (82.7) (151.8) (46.1) (93.2) (57.3) (28.1) (37.7) (25.6) (25.7) (44.2)